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LYMPHOCYTE-INDUCED ANGIOGENESIS : A QUANTITATIVE
AND SENSITIVE ASSAY OF THE GRAFT-VS.-HOST REACTION*
By YOUNAN A . SIDKY AND ROBERT AUERBACH
(From the Department of Zoology, University of Wisconsin, Madison, Wisconsin 53706)
While progress in achieving quantitative measures of cellular immune responses
has been rapid since the advent of various in vitro correlates of cell-mediated
immunity (1-6), the need for a quick and precise measurement of such responses
in vivo remains . Such measures as mean survival time after injection of
immunocompetent cells into adult allogeneic irradiated hosts (cf. 7), for
example, or mean graft survival time after skin transplantation suffer from
excessive variability, length of time required for completion of the assay, and
procedural difficulties . The induction of splenomegaly in neonatal recipients of
allogeneic cells (8) is reasonably quantitative but operationally restrictive . Other
assays such as enlargement of draining lymph nodes (9) or hepatic lymphoid
infiltration (10), although more sensitive and more directly reflecting numbers of
effector cells, are limited in applicability; the latter, moreover, requires histol-
ogy . Local graft-vs.-host reactions have also been assessed by damage to the host
kidney after injection of allogeneic immunocompetent cells under the kidney
capsule (11), and by skin reactions elicited by intradermal inoculation of such
cells (12) ; the latter has been called the normal lymphocyte transfer reaction (12,
13).
The normal lymphocyte transfer reaction seemed to us to have the greatest
potential advantage for an in vivo assessment of immunological disparity
between donor and host . The extensive studies of Brent and Medawar (12, 13)
and of Billingham and his colleagues (14, 16) established the reaction as
reflecting a local graft-vs.-host reaction . Their assessment of the strength of
reaction was based on measurements of a local swelling, induration of the skin
and erythema ; other adjuncts of inflammation have also been reported (17, 18) .
Our own work has been directed at assessment of the host local vascular re-
sponse which under appropriate experimental conditions can serve as a rapid,
reliable, and quantitative measure of the activity of intracutaneously injected
immunocompetent lymphocytes .
Materials and Methods
Animals . Mice were from our own colony-included BALB/cAu, C57BL/6JAu, C3H/HeAu,
BALB/c x C3H (F,), and nu/nu backcrossed for 5+ generations to BALB/cAu . Additional animals
obtained commerically included C3H and BALB/c (Charles River Laboratories, Wilmington, Mass .),
C57BL/10 and C57BL/10D2 (Jackson Laboratories, Bar Harbor, Maine) and C57BL/6 . DBA/2, BDF1
* Supported by U . S . Public Health Service NIH Grants AI 11926 and CA 13548 and National
Science Foundation grant GB 36767 .
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and HaICR/SCH (ARS Sprague Dawley). In general, donors and recipients were adultmales, 2-4 mo
old; exceptions are noted in the text.
Cell suspensions.
￿
Donorcell suspensions were obtained in normal saline by teasing andabrasion
against a stainless steel screen. Further disruption of clumps was achieved by passing the cell
suspension in and out of a syringe. Cell suspensions were washed twice in saline, viability was
assessed by trypan blue exclusion, and the cell concentration was then appropriately adjusted.
Irradiation.
￿
Irradiation was carried out with a GE Maxitron X-ray machine (General Electric
Co., West Lynn, Mass.) operatingat 300kvp, 20 mA, dose rate of 83 R/min in air, with 1 mm Cu and
1/2 Al added filtration. Unless otherwise indicated, animals were irradiated with 800 R no more than
24 h before injection of test cell suspensions. Donor cell suspensions were irradiated in saline.
Cell 7}ansfer. Intracutaneous injections were performed with a 27 gauge needle which was
introduced about 1 /2 cm into the skin as close to the epidermis as possible. 0.1 ml of volume was
injected in all instances. Experiments designed to validate the methodology indicatedthat indeed up
to eight injection sitesperanimal couldbe used (cf. TableIA), andthat the various sitesdidnotyield
significantly different results; only the mid-dorsal and mid-ventral regions need to be avoided. In
most experiments, however, animals received only four injections.
It was noticed that occasionally one recipient was astronger or weaker responderthan most of the
animals used in a given experiment. Forthis reason inoculation of allexperimental groups into each
animal was favored, and this type of protocol was used throughout our experiments.
Vascular Response Assay.
￿
Mice were killed by ether, anda mid-ventral incision wasmade in the
skin which was then separated carefully from the underlying muscles. Further steps were carried out
with theaidof adissecting microscope. Scoring of allof thereaction areaswascarried out at thesame
magnification (7 x) and only vessels readily detected at this magnification were counted. Weaker
responses, examined under higher magnification, would otherwise give erroneously high counts.
Transmitted light wasused to examine albino mice, butdirect light hadto be used on mice with dark
skin. The sites of injection, recognized by local swelling or discoloration, were exposed by carefully
removing fator other tissue covering thearea. Most recently we have foundthat addition of adrop of
trypan blue to the cell inoculum so that the cell suspension becomes lightly colored, simplifies
subsequent location of the sites of injection. Gentle stretching of the skin with forceps also helps
visualization of the reaction area.
Allextra bloodvesselsconnectedwith thescar region, andcontrasting with thenormal background
vasculature, were counted; these vessels were readily detected because of their tendency to loop
formation and tortuosity. The change in shape of vessels ranged from minimal zigzagging to
formation of a complete loop depending on the degree of histoincompatibility and the time of assay,
but each extra branch was counted as one regardless of its state of deformity. Additional looped
vesselswere occasionally seen farther away from the injection site, butthese were notincluded in the
count because they were considered too variable to be included as a meaningful measure of the
response under study.The counting procedure maybe more readily understood by referring to Fig. 1
a-c and Fig. 2.
Once the assay guidelines were established, technicians could read the reaction within t 10%.
However, virtually all data included in the present report were counted by the same person (Y. A.
Sidky) . To assure absence of bias representative experiments for each series were carried out using
coded suspensions ; where feasible coding of host animals was also used.
Presentation of data.
￿
No experiments is included in more than one table. In some instances a
correction factor of 0.85 has been applied to day 3 data to permit pooling of day 2 and day 3
measurements. Calcualtion of this factor was based on the means of 50 consecutive experimental
groups for which both day 2 and 3 data were obtained .
Other.
￿
Corticosteroid-resistant thymocytes were produced by intraperitoneal injection of 2.5 mg
hydrocortisone acetate 2 days before utilization of the thymus. Mitomycin-C treatment was carried
out by incubation of cells for 30 min with 25 ug/ml of mitomycin-C (Sigma Chemical Co., St. Louis,
Mo.), followed by careful washing.
Results
General Description.
￿
Transfer of spleen cells into the skin of adult irradiated
and nonirradiated recipients results in the appearance of a thickened yellowishFIG. 1 .
￿
(a) 2 x 10 , BALB/c spleen cells were injected into irradiated HaICR mice 3 days
before assay . Since the reaction is three-dimensional, the photograph does notshow all vessels
with the same degree of clarity . (x 10) . (b) Drawing of the reaction site shown in Fig . 1 a . S
indicates scar region . Blood vessels in region A and the upper part of region F are not
considered part of the reaction . Counts : A = 0 ; B = 6 ; F = 4 . For counts of C, D, and E see
Fig . 1 c . (c) Detail of region surrounding scar (see also Fig . 2) . Counts : C = 16-18 ; D = 4 ; E _
11 .
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scar at the site of injection, which is readily detected after 24 h irrespective of the
genetic compatibility or incompatibility between donor and host animals . When
isologous spleen cells are inoculated (2 x 106-4 x 106 cellswere routinely injected
as controls) a scar was visible at the site of injection ; this scar persisted for 2-4
days . The scar was sometimes reddish, but few, if any extra blood vessels were
FIG . 2 .
￿
2 x 10 8 allogeneic cells (BALB/c-HaICR), day 3 . Same region as shown in Fig . 1 b .
FIG . 3 .
￿
4 x 108 isogeneic cells (HaICR), day 2 . x26 .
FIG . 4 .
￿
8 x 10 8 allogenic cells (BALB/c-HaICR), day 2 . Halo around scar region . x 11 .
FIG . 5 .
￿
As Fig. 4, 1 day later, Halo has cleared and extensive vascular response isnow seen .
x 1l .1088
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directly associated with the scar and their number and appearance did not
change over a 6-day observation period (Fig. 3) .
When immunocompetent cells are injected into histoincompatible hosts,
however, the scar region becomes surrounded by an intricate network of blood
vessels which in spite of its complexity, can be characterized in quantitative
terms (Figs. 1 and 2) . By enumerating distinct vessels, i.e. by counting every
discrete vascular branch arising by divarication, it is possible to assign a number
value to the vascular reticulation induced by foreign lymphocytes. The results,
presented in Tables I-X, indicate that the number thus determined bears a
direct and meaningful relationship to the number of cells injected, immunologi-
cal state of competence of the injected cells, and the degree of histoincompatibil-
ity between donor and recipient.
Effect of Cell Concentration.
￿
While cell concentration studies were carried
out with numerous strain combinations, the most extensive series of experiments
was performed using BALB/c donor spleen cells assayed in HaICR host animals.
This line is genetically uniform as determined by nonstimulation in mixed
leukocyte culture and by retention of skin grafts (19) . The use of this strain
combination for many of our experiments was dictated by the ready availability
of animals, ease of scoring, and the virtually complete absence of background
vasculature in animals injected with syngeneic cells.
TABLE I A
Effect of Cell Dose on Number of Vessels Induced by BALBIc Spleen Cells Injected
Intracutaneously into Irradiated HaICR Mice
Single experiment; each animal received eight injections.
* Not found
$ 2 x 10° HaICR spleen cells
§ Not injected
Animal no.
Cell dose x 10-": 02
No.
0.5
of extra
0.75
vessels
1.0 2.0 3.0 4.0 Syn.f
Assay: day 2
I 0 9 13 21 26 29 27 0
II 0 12 15 18 26 27 § 0
III 13 18 20 25 29 31 2
IV 11 15 19 21 31 30
V 7 16 18 23 28 30 0
VI 8 13 19 24 25 28 0
VII 4 14 20 30 35 37 45 0
X 0.6 10.6 15.7 20.7 25.7 29.4 32 .2 0.3
Assay: day 3
VIII * 27 30 37 45 47 36
IX 3 17 21 32 39 44 43 3
X 0 17 19 25 31 33 35
XI 4 i4 20 22 25 29 32 0
XII 0 17 29 32 35 46 52 2
X 1.4 18.4 23.8 25.6 35.0 39.8 39.6 1 .0TABLE I B
Effect of Cell Dose on Number of Vessels Induced by BALB/c
Spleen Cells Infected Intracutaneously into Irradiated
HaICR Mice
Cell dose (x 10- e)
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R vessels t SE
Single experiment; each animal received eight injections.
*Six animals/group.
fFour animals/group.
§Halo around scar region.
TABLE I C
Effect of Cell Dose on Number of Vessels Induced by BALB/c
Spleen Cells Injected Intracutaneously into Irradiated
HaICR Mice
Three additional experiments, consecutive, assay day 2.
* Syngeneic cells at doses from 2 x 10° to 4 x 10"; all experiments
included.
The results of a single experiment involving BALB/c spleen cells injected into
HaICR mice are presented in Table I A. In this experiment each animal was
given eight separate injections, and animals assayed on day 2 or day 3 are listed
individually to illustrate the type ofexperimental design and results obtained. A
second experiment, involving higher numbers of cells, is summarized in Table I
B. Table I C includes the pooled results of three additional experiments. The
results presented for the BALB/c-HaICR combination are consistent with results
obtained for a variety ofother strain combinations, onlysome of which are listed
in Table II.
Cell dose (x 10-°) No.of
animals Xvessels f SE
0.2 19 1.47 t 0.40
0.5 26 9.42 f 0.62
0.75 29 13.24 t 1.19
1.0 28 22.43 t 0.82
2.0 12 26.08 t 1.08
3.0 6 31.50 1.72
4.0 12 37.50 t 1.72
Syn.* 107 0.15 t 0.01
Assayday 2* Assayday3t
1 16.7 f 1.0 16.8 t 2.8
2 25.5 t 1.3 25.3 t 3.3
4 29.3 t 2.3 23.3 t 3.4
6 33.3 f 2.1§ >60
7 31.2 t 1.6§ >60
8 29.3 t 1.8§ >60
10 34.2 t 2.5§ >60
Syngeneic 0.8 t 0.5 01090
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TABLE II
Effect of Cell Dose on Vascular Response: Individual Experiments;
Various Strain Combinations
The tables show that the number of looped vessels increases linearly with
increased number of inoculated immunocompetent cells up to 1 x 106 cells.
Injection of more cells, up to 4 x 10 6, caused a progressively smaller increase of
looped vessels. The use of higher concentrations of spleen cells (6 x 106-10 x 106
cells) was not reflected in an increase in the number of vessels observed on day 2
(Table I B) . Rather the injection led to the formation of a bigger scar, thickening
and induration of the skin, and the appearance of a red halo around the site of
injection (Fig. 4, cf. also 14). The presence of a halo either prevented the
formation or detection of more vessels than observed at lower concentrations of
cells; once this halo had cleared on the following days, however, an extensive
network of blood vessels was observed (Fig. 5, cf. Table I B) .
Host strain
No. of animals
per group
Cell dose X vessels f SE
BALB/c donor spleen cells (x 10-e)
C3H 5 0.5 8.3 t 4 .1
1 .0 17.6 t 2 .7
2.0 26.2 t 4 .2
4.0 40.2 t 4 .2
C57BL/6 6 1.0 9.1 t 1.1
2.0 14.7 t 2 .4
3.0 25.3 f 1 .6
4.0 33.4 f 4.0
HaICR 8 1 .0 15.6 t 1 .5
3.0 31.0 t 1 .7
4.0 40.1 f 2.3
BALB/c x C3H 6 1 .0 12.5 f 0 .8
2.0 20.5 t 0.6
4.0 32.9 t 3.4
C57BL/6donor spleen cells
BALB/c x C3H 7 1 .0 4.9 f 2 .4
2.0 13.4 f 2.5
4.0 29.6 f 3.3
BALB/c 5 1 .0 12.7 t 1 .5
2.0 14 .4 t 0.7
3.0 23 .7 t 1.6
4.0 30.3 t 1.4
C57BL/6xDBA/2 8 0.2 4.3 t 0 .8
0.5 14.4 t 0.6
0.8 19.5 t 1.1
1 .0 22.1 t 2 .2
2 .0 30.9 f 1 .1
3.0 34.3+3 .6
4.0 38.6 t 2 .1Time-Course of Vascular Responsiveness .
￿
A variety of strain combinations
were employed in assessing the progressive changes of the vascular pattern with
time . The pattern was similar for all combinations studied (Table III) . In the case
of strong histocompatibility differences, the effect of injecting allogeneic cells
could be detected within 24 h, but the vascular bed appeared faint and looping
was minimal . During the second and third day, the number ofdeformed vessels
increased and their pattern became clearly discernible . Subsequent to this time,
the amount of looping was found to increase, but quantitation of the response
became more difficult . In general, injection of 3 x 106 cells or less resulted in a
TABLE III
Time-course of Vascular Response Induced by BALBIc Spleen Cells Injected
Intracutaneously into HaICR Irradiated Mice ; Representative Experiment
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maximum response by day 3 or 4, while above that concentration additional
vessels and vascular contortions could be observed until day 6. A limitednumber
of small hemorrhages (petechiae) tend to appear at those reaction sites which
persist to the sixth or seventh day at which time almost all the reactions have
already declined . From this it appears that readings made 2-3 days after
inoculation are optimal for measuring the induced vascular responses for the cell
doses most frequently used in the present study .
Effect of Irradiation of the Host on Vascular Responsiveness .
￿
Our original
reason for irradiating host animals was to prevent a host-vs.-graft reaction in
allogeneic strain combinations . However, it readily became apparent that
irradiation served to reduce variability and increase the number of blood vessel
divarications not only in allogeneic but in semiallogeneic combinations as well
(Fig . 6) .
Effect of Irradiation and Mitomycin-C Treatment of Donor Cell Suspensions
on Their Ability to Induce Angiogenesis . When competent donor cells were
irradiated in vitro with 1,000 R X-rays, a significant response was nonetheless
apparent 48 h after inoculation (Table IV) . However, this response was a
transient one and the number of vascular branches decreased rapidly thereafter .
Similarly, when donor lymphocytes were treated with mitomycin-C before
transfer the response over the first 2 days was normal but again there was a rapid
decline after this time .
Distribution of Cells Competent to Induce Angiogenesis . A survey was
carried out to ascertain the efficacy of cells from various lymphoid organs to
Days after
Inoculation 1
Cell dose (x 10-e)
2 4
No . of
animals/
group
X vessels + SE
1 9.8 +0.3 13.5 + 1.0 14.8+ 3 .0 4
2 16.3 + 1.7 28.8+2.3 40 .5 + 4 .3 4
3 17.5 +3.1 39 .0 + 2.7 46 .5 + 3.0 4
4 23.7+4 .2 45.7+3.8 61.3+17.9 3
5 37.3+8.4 54.3+6.2 72.7+12.0 3
6 38.0 +9.9 61 .0 + 15.9 69.0+ 19 .0 3
7 11.0+1.0 27.0+6 .0 70.5+14.5 21092
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DONOR RECIPIENT
C3H -(CxC3H)FI
BALB/C -(Cxr,3H)Fl
BALB/C-C3H
C3 H-C57BL/6
BALB/C-C578L/6
C57BL/6-BDF1
BALB/C-+BDFi
* No . of mice in parentheses .
ONONIRRADIATED RECIPIENT
=800R
NUMBER OF VESSELS
FIG . 6 .
￿
Effect of irradiation of host animals on the extent of vascular response induced by
foreign lymphocytes (individual experiments) .
TABLE IV
Effect of Mitomycin C or 1,000R Irradiation on the Subsequent Ability of3x 10 8BALB/c
Spleen Cells to Induce Angiogenesis in Allogeneic Mice (Pooled data)
Assayed after :
￿
Assayed after :
Treatment
induce a vascular response . Spleen, lymph node, thymus and bone marrow cells
from individual animals were compared, as shown in Table V . Lymph node and
spleen cells both induced a strong response, while thymus and bone marrow were
unable to do so . Hydrocortisone-resistant thymocytes, on the otherhand, showed
competence equivalent to that of spleen cells.
Since these experiments suggested that the effector cell population was of
thymic origin or thymus-dependent, spleen cells from thymusless (nu/nu) mice
were studied and compared to spleen cells from their littermates. The experi-
ments showed that spleen cells from thymusless animals are not capable of
evoking a host vascular response (Table VI) .
The ontogeny of spleen cell competence to induce angiogenesis was also
examined . Newborn spleen cells lacked adequate numbers of effector cells . 4
days after birth, however, sufficient numbers of competent spleen cells were
present to mount a weak but detectable response, as shown in Table VII .
Genetic Aspects of Lymphocyte-Mediated Angiogenesis .
￿
A variety of strain
2 days 3 days
X vesselsf SE
4days
None 31.3 t 2.1 (8)* 37.0 t 4.0 (5) 56.0 f 1 .7 (3)
Mitomycin-C 26 .4 t 2.3 (8) 11.6 t 2.0 (5) 4.0 f 4.0 (3)
1,000 R 16.6 t 1.9 (5) 11.0 t 3.2 (5) 5 .7 t 5.7 (3)YOUNAN A . SIDKY ANDROBERT AUERBACH
TABLE V
Organ Distribution of BALB/c Cells Competent to Induce
Angiogenesis in HaICR Host Mice (Representative Experiment)
Source ofdonor cells
*No . of mice in parentheses .
Assayed after :
* 2 x 10" cells .
$ Hydrocortisone-resistant thymocytes. Although 2 x 10° cells were used,
in this experiment the thymus was larger than usual, i.e., steroid
treatment was not fully effective . In other experiments 0.4 x 10,
hydrocortisone-resistant thymus cells were as effective as 3 x 10" spleen
cells .
§ Six animals/group .
11 Four animals/group .
TABLE VI
Ability of Spleen Cells from Congenitally Athymic (nu/nu) BALB/c Mice to Induce
Angiogenesis in Various Strains of Mice: Pooled Experiments
Host Strain
1093
combinations were used throughout the studies already reported, all conforming
to the pattern of a graft-vs.-host reaction . Thus, positive reactions were obtained
both in allogeneic combinationsand in semiallogeneic ones where donor parental
cells were injected into recipient F, cells, on the other hand, did not generally
cause a reaction in parental strains . Reciprocal experiments designed to test this
point specifically are shown in Table VIII .
To assess the role of H-2 disparity, combinations between C57BL/10 and
C57BL/10D2 were carried out . The experiments show that congenic resistant
lines differing only in the major histocompatibility region (in this case B vs . D)
cause a vigorous vascular response (Table IX) .
In combinations involving BALB/c and DBA/2 (H-2 compatible, M disparate)
a low but detectable response was obtained (Table X) . It should be pointed out,
moreover, that in addition to seeing fewer vascular branches, the degree of vessel
C3H HaICR
Xvessels t SE
BDF,
nu/nu 1.9 t0.9 (6)* 0.3 t 0.3 (12) 0.0(8)
nu/+ or +/+ 17.9 f 3.1 (5) 20.6 f 3.0 (11) 10.5 t 2.1 (8)
BALB/c 20 .5 t 2 .9 (4) 21 .7 f 2.7 (11) 18 .1 t 2.7 (8)
Source of cells*
Bone marrow
2days§
Xvessels f
0+0
3 days 11
SE
0 t 0
Thymus 1.5t 0.7 0.5 f0.5
Spleen 19.8 t 1.0 19.8 f 1.8
Lymphnode 28.5 t 1.3 39.2 f 3.1
Steroid thymus$ 16.0 t 1 .4 9.0 f 0.6
HaICR spleen 1.0 :1: 0.5 0 t 01094
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TABLE VII
Ontogeny of Ability of BALE/c Spleen Cells to Induce Vascular
Response in HaICR Recipients: Representative Experiment
* 2 x 10° cells .
TABLE VIII
Graft-us.-host Nature of Induced Angiogenesis: Reciprocal
Experiments between Parental and F, Mice (Representative
Experiment)
* 2 x 10° cells. Correction factor applied for day 3 observations .
$No. of mice in parentheses.
TABLE IX
Lymphocyte-mediated Angiogenesis Induced by Spleen Cells
Differing only at the H-2 Region: Pooled Experiments
Source of donor
cells*
Host strain
C5713L/10 C57BL10:D2
Xvessels t SE
C5713L/10
￿
1 .4 t0.4 (14)$
￿
21 .3 t 2.1 (13)
C571310:D2
￿
17.8 t 1 .8 (13)
￿
1.0 t0.4 (13)
* 3 x 108 cells. Correction factor applied for day 3 observations.
$No. of mice in parentheses.
deformity is also less when a non-H-2 difference is involved, and the decline of
the reaction is rapid.
Discussion
Our experiments describe a new and sensitive assayfor the effect of intracutane-
ous administration of immunocompetent lymphocytes into the skin of unimmu-
nized hosts (the normal lymphocyte transfer reaction). The assay is based on the
Ageofdonor*
No. of
animals Xvessels t SE
Newborn 10 0t 0
4-day old 15 14.4 t 1 .3
8-day old 10 13.8 t 1 .7
Adult 10 23.0 f 2.2
Syngeneic adult 10 0.8 :*: 0.6
Source of donor
cells*
C57BL/6
Host strain
C57BL/6 x DBA/2(BDF,)
Yvessels t SE
C57BL/6 1.5 f 0.7 (84 24.7 t 2.3 (6)
BDF, 3.1 t 0.9 (8) 0.9 t 0.6 (6)
BALB/c 21.5 t 1 .8 (15) 24.3 t 1.1 (12)TABLE X
Vascular Response to Immunocompetent Cells in the Absence of
H-2 Incompatibility: BALB/c vs. DBA/2
Source of donor
cells*
YOUNAN A. SIDKYAND ROBERT AUERBACH
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Xvessels t SE
BALB/c
￿
0.5 f 0.4 (7)$
￿
11.0 t0.5 (6)
DBA/2
￿
8.7 t 1.9 (6)
￿
0.0(6)
C57BL/6
￿
26.7 f 1.9 (6)
￿
39.3 t4.1 (6)
* 3 x 108 cells.
$No. of mice in parentheses.
Host strain
BALB/c DBA/2
measurement of induced vascular reticulation . We have named this response
lymphocyte-induced angiogenesis (LIA)' for reasons to be discussed below. The
assay is rapid, with accurate assessment of the reaction possible within 48 h after
injection of immunocompetent cells; it is capable of detecting in vivo the action
of as few as 5 x 105 spleen cells differing at the H-2 locus; it can detect some
non-H-2 differences such as M locus disparity; and it shows dose-dependent,
quantifiable effects.
As is the case for the previously described normal lymphocyte transfer
reaction, LIA is a manifestation of the graft-vs.-host reaction. This conclusion is
supported by the following findings : (a) allogeneic or semiallogeneic cells readily
induce angiogenesis while syngeneic cells fail to do so; (b) F, cells injected into
parental-strain animals are unable to induce significant angiogenesis; (c) at
concentrations where spleen and lymph node cells can induce a response, thymus
and bone marrow cells are ineffective ; (d) on the other hand the small number of
hydrocortisone-resistant cells found in the thymus show strong reactivity; (e)
cells from thymusless (nu/nu) donors cannot induce a vascular response, while
their littermates initiate a normal response; (f) combinations between BALB/c
and DBA/2 result in a weak but detectable response ; (g) the newborn spleen does
not contain LIA-competent cells but competent cells appear by day 2 and
gradually increase in relative frequency.
It should be kept in mind that the LIA assay, as is the case for pock-formation
on the chorioallantoic membrane (20) or splenomegaly induced in neonatal
animals (8) relies on amplification by the host in response to graft-vs.-host
activity of immunocompetent lymphocytes. A host response also represented a
major element in previous measures of the normal lymphocyte transfer reaction,
such as swelling, erythema and induration of the skin (12-16), or increased
vascular permeability as measured by Evans blue leakage (18) ; since the LIA
assay measures only the vascular pattern of the host, however, it appears to offer
a greater opportunity for analysis of the reaction .
In this connection, the observation that irradiation of recipient animals before
lymphocyte transfer increases the reliability and sensitivity of the LIA assay
should be discussed. Ramseier and Billingham (15) found that irradiation of
'Abbreviation used in this paper: LIA, lymphocyte-induced angiogenesis.1096
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hamsters before lymphocyte transfer impaired the reaction, and a similar
observation was made with respect to the host kidney response to a local
graft-vs.-host reaction (11). Since the LIA assay measures an endothelial
response, however, the known radio-resistance of resting endothelial cells
combined with the increased vascular permeability induced by irradiation (21)
would appear to be most favorable. At the same time host irradiation, by
destroying host immunocompetent cells, permits the use of allogeneic donors
without the complicating factors of a host-vs.-graft reaction .
It is most encouraging that relatively low numbers of cells are needed to elicit
detectable vascular reticulation. Indeed, when higher numbers of effective cells
are injected locally the vascular response rapidly becomes obscured by indura-
tion and erythema ; it is this aspect of the response that was investigated so
extensively by Streilein and Billingham (14) who injected 107 cells in their study
of the normal lymphocyte transfer reaction. Since LIA can be detected after
inoculation of as few as 5 x 105 cells, a highly active mediator of endothelial
response is indicated.
While our experiments show that H-2 differences are sufficient to evoke LIA,
we have not yet further dissected the H-2 region to ascertain the relationship of
ability to evoke vascular reticulation to the Ir, LD, or other subsections of that
region; such experiments are in progress. The fact that differences between
BALB/c and DBA/2 are read as weak reactivities is encouraging in the light of
related findings reported by Salaman et al . (22) and by Auerbach and Shalaby
(23), and suggests that the host response to transfer of normal lymphocytes is not
entirely restricted to H-2 incompatible combinations as suggested by Streilein
and Billingham (14) .
Our finding that mitomycin-C treatment or irradiation of donor lymphocytes
does not abrogate the initiation of a vascular response, but does prevent its
continuation can be interpreted to reflect on the need for cell division for
amplification, and/or to the rapid removal of treated cells from the site of
injection, presumably by host phagocytes . If the later response to normal
lymphocytes is based on a different effector cell population it may of course be
possible that such a population of cellsis indeed more radiosensitive than the one
initiating LIA. Brent and Medawar (12, 13) suggested that the normal lympho-
cyte transfer reaction proceeds in two phases, a recognition phase within thefirst
two days which does not require cell division, and flareup phase which occurs
subsequently and which is eliminated in the absence of cell division .
In vitro studies have shown that lymphocytes, in response to the first phase,
produce a variety of mediators or soluble factors (cf. 4, 24), such as migration
inhibition factor, mitogenic factor, blastogenic factors, macrophage-activating
factor, skin-reactive factor, and interferon (6, 24); such mediators may well
provide the appropriate stimulus for host endothelial cell responses, thus
acting as an angiogenesis factor as well and leading to the observed alterations in
vascular pattern.
The described skin reaction can probably be applied to other types of delayed
hypersensitivity, e.g., the tuberculin reaction, other bacterial antigens, serum
proteins or other simple protein antigens, etc. (25) . Preliminary experiments on
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resulting delayed hypersensitivity (26) can be measured by our assay protocol ;
sensitized mice should not be irradiated however . We have also been able to use
the hamster as a recipient, and it has been possible to assay for activity of
xenogeneic cells.
The similarity between the vascular response induced by foreign lymphocytes
and that induced by grafted tumor tissue or tumors in situ is striking and
intriguing . Operationally, tumor-induced angiogenesis (cf. 27, 29) and lym-
phocyte-mediated vascular reticulation are indistinguishable . Moreover, in
experiments to be reported elsewhere (footnote 2) we have observed that lymph
node grafts placed in assay situations developed for tumor angiogenesis studies,
i .e . intracorneal grafts in rabbits and chorioallantoic membrane grafts in chick
embryos, are capable of evoking host angiogenesis and the kinetics of these
responses appear comparable . Furthermore in these assays there is clear evidence
for angiogenesis as distinguished from changes in vascular visualization through
constriction and vasodilation, which could certainly play a significant role in the
observed intradermal responses . It is of interest in this connection that
irradiation oftumor cells also fails to inhibit their ability to initiate angiogenesis
in vivo (30) or to release tumor angiogenesis factor in vitro (31) . The meaning of
the similarity between these two systems remains enigmatic, although the role of
a common mediator of angiogenesis is certainly a distinct possibility .
The possible interrelationship between lymphocyte-induced angiogenesis and
tumor-induced angiogenesis bears further consideration . Aside from the possible
direct action of a tumor-originiating mediator of angiogenesis (TAF) (27), could
there be an additional vascular response resulting from lymphocyte recognition
oftumor antigens? Such a reaction could act synergistically, and its absencemay
well restrict the rate of tumor progression. Indeed the contradictory findings in
studies oftumor growth in nu/nu mice (cf . 32) and the restriction oftumorgrowth
and metastasis after a graft-vs.-host-induced lymphopenia (33) may find their
explanation in just such lymphocyte-mediated amplification of angiogenesis .
Aside from the extensive vascular changes associated with delayed hypersensi-
tivity and inflammation, a number of disease states exist in which neovasculari-
zation plays an integral part (e .g . diabetic retinopathy) . The demonstration that
thymus-derived lymphocytes can cause an increase in local vascularization as
reflected both in the number and tortuosity of vessels associated with the activity
of those cells may well prove to be significant in this respect. Similarly, the
observed increased size of placental mass and vasculature in histoincompatible
fetal-maternal combinations (34) and especially after previous immunization of
the mother against paternal antigens suggests that LIA may be a meaningful
response in a variety of physiological conditions requiring vascular adaptation .
Anumber of experiments are in progress to further define the nature ofLIA : to
establish the pattern of ontogeny of immunocompetence as measured by this
reaction ; to ascertain the potential of using the vascular response as an indirect
measure of immune reactivity between mixtures of xenogeneic celi populations
(bystander assay) ; to define more precisely the source of target cells responding
to the lymphocyte-derived stimulating material ; and to characterize the nature
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of material released by lymphocytes undergoing a local graft-vs.-host reaction.
We expect that these experiments will increase our understanding of the
mechanism and significance ofvascular changes mediated by immunocompetent
lymphocytes.
Summary
A new and sensitive assay for the effect of intracutaneous administration of
immunocompetent lymphocytes into the skin ofirradiated unimmunized mice is
described. The assay, which we have termed lymphocyte-induced angiogenesis
(LIA) involves enumeration of new vascular branches induced by the action of
these competent cells. As is the case for the previously described normal
lymphocyte transfer reaction, LIA is a manifestation of the graft-vs.-host
reaction, as shown by experiments utilizing appropriate genetic combinations.
The reaction isdose-dependent, and within the dose range of2 x 105-4 x 106 cells
the number of vessels induced correlates with the number of immunocompetent
cells injected . At these dose levels spleen, lymph node, and hydrocortisone-resist-
ant thymocytes are effective; bone marrow and thymus cells are not. Spleen cells
from nude mice are incapable ofinducing LIA, while mitomycin-C and irradiated
lymphocytes can initiate but not maintain the reaction . The relationship
between lymphocyte-induced angiogenesis and tumor-induced angiogenesis has
been discussed as have the implications of these findings to delayed hypersensi-
tivity, inflammation, and vascular pathology.
The technical assistance of Larry Morrissey, Francis M. McCormick, and Louis Kubai isgratefully
acknowledged.
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